Adhesiolysis in Severe and Reccurent Cases of Adhesions Related Disorder (ARD) - A Novel Approach Utilizing Lift (Gasless) Laparoscopy and SprayGel™ Adhesion Barrier

Abstract:

We investigated the feasibility and outcome of adhesiolysis in patients with severe and reccurent adhesions using lift (gasless) laparoscopy and a SprayGel™ adhesion barrier at the Institute for Endoscopic Gynecology (EndoGyn®). The design included a prospective evaluation of lift (gasless) laparoscopic adhesiolysis in combination with a SprayGel™ adhesion barrier. A new score for bowel adhesions was developed and applied. All 35 patients with severe and reccurent adhesions underwent a lift-laparoscopic adhesiolysis with the Abdo-Lift™ and SprayGel™ adhesion barrier, a second-look laparoscopy at Day 7 and, in case of continuation of pain, a third-look laparoscopy within 6 months after the initial surgery. All patients were operated upon without conversion to laparotomy. The reduction in the adhesion score of adhesions at the second-look laparoscopy was overall (sum) 89.8% (90.1% reduction in extent, 89.3% reduction in severity, and 89.9% reduction in grade). Five patients (14.3%) had a third-look laparoscopy within 6 months after the initial surgery, in which four cases of adhesion reformation were confirmed. However, the scores were reduced compared to the initial surgery, especially in grade (94.2%) and severity (93.2%). In these analyses, SprayGel™ was uniquely effective in improving the success rates of adhesiolysis when combined with lift (gasless) laparoscopy and good hemostasis techniques. Adhesiolysis with Abdo-Lift™ and SprayGel™ had unparalleled efficacy in the adhesiolysis procedure even in those patients in whom other solutions have not worked. An overall reduction of adhesions by 89.9% at second-look laparoscopy was found. Even if five patients (14.3%) required a third-look laparoscopy where four cases of adhesion reformation were confirmed, the scores were reduced when compared to the initial surgery, especially in grade and severity.

Authors:

Daniel Kruschinski, M.D.; Shirli Homburg, Ph.D.; Fabian D'Souza, M.D.; Patrick Campbell; Harry Reich, M.D., Institute for Endoscopic Gynecology (EndoGyn®), Seligenstadt, Germany

Buy and download instantly for only $69!

$69.00
Order Article Copies 

For Direct IP Access please click this link